Clinical Trials

Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Diagnostic Test
  • Participants: 410
  • Start Date: January 2022
Optimization of Sepsis Therapy Based on Patient-specific Digital Precision Diagnostics
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Drug
  • Participants: 200
  • Start Date: August 30, 2021
The Effect of Dexmedetomidine on the Incidence of Acute Kidney Injury in EVAR
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Participants: 200
  • Start Date: August 1, 2021
New Methods for Early Detection of Acute Kidney Injury After Heart Surgery
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 4000
  • Start Date: August 2021
Personalized Recommendations for Acute Kidney Injury (AKI) Care Using a Kidney Action Team: A Randomized Trial
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 3375
  • Start Date: July 1, 2021
Telemedicine Notifications With Machine Learning for Postoperative Care
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 50
  • Start Date: June 15, 2021
Evaluation of Valproic Acid (VPA) as Adjunctive Therapy for Liver Transplant Patients With Moderate to Severe Hemorrhage at Risk of Ischemia Reperfusion (I/R) Injury
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 50
  • Start Date: June 15, 2021
Evaluation of Valproic Acid (VPA) as Adjunctive Therapy for Trauma Patients With Moderate to Severe Hemorrhage at Risk of Ischemia Reperfusion (I/R) Injury
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Drug
  • Participants: 80
  • Start Date: April 15, 2021
Urine Alkalinisation to Prevent AKI in COVID-19
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 100
  • Start Date: April 2021
NIRVANA: NIcotinamide Riboside in SARS-CoV-2 pAtients for reNAl Protection
Clinical Trial
  • Status: Not yet recruiting
  • Phase: N/A
  • Intervention Type: Device
  • Participants: 50
  • Start Date: April 2021
Evaluation of Daily Hemodialysis With Low Dialysate Flux in Unscheduled Patients With Kidney Injury Admitted to Hemodialysis
Showing 1-12 of 213